Related Experiment Video
Updated: Jun 17, 2026

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Point-of-care coagulation testing and transfusion algorithms
L J Enriquez1, L Shore-Lesserson
1Montefiore Medical Center, Department of Anesthesiology, Bronx, NY, USA.
Insights
Cardiovascular patients often have bleeding risks and require monitoring of coagulation. This review covers essential monitoring tools for heparin, platelet function, and anti-platelet drugs during cardiac surgery.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Anesthesiology
Background:
- Patients with cardiovascular disease (CVD) exhibit hemostasis disorders, increasing risks of thrombosis and embolism.
- These patients frequently use anti-thrombotic medications to prevent adverse cardiovascular events.
- Cardiac surgery patients present complex hemostatic challenges due to underlying conditions, medications, and cardiopulmonary bypass.
Purpose of the Study:
- To review available perioperative coagulation monitoring systems.
- Emphasis is placed on monitoring relevant to cardiovascular surgery.
- To discuss specific monitors for heparin, platelet function, and anti-platelet agents.
Main Methods:
- Literature review of perioperative coagulation monitoring techniques.
- Focus on monitoring strategies applicable to cardiac surgery.
- Discussion of heparin assays, platelet function tests, and anti-platelet drug monitoring.
Main Results:
- Various monitoring tools exist for perioperative coagulation management.
- Heparin monitoring is crucial for patients on anticoagulation.
- Platelet function monitoring aids transfusion decisions, and anti-platelet drug monitoring is vital.
Conclusions:
- Effective perioperative coagulation monitoring is essential for patients with CVD undergoing cardiac surgery.
- Utilizing appropriate monitoring tools can mitigate bleeding risks and improve patient outcomes.
- The review highlights key monitors for heparin, platelet function, and anti-platelet therapies.
Abstract:
Patients with cardiovascular disease have an array of haemostasis disorders that predispose to the development of thrombotic and embolic disease states. These patients are often maintained on anti-thrombotic medication to prevent adverse cardiovascular events. Patients undergoing cardiac surgery also have haemostatic disorders that include their intrinsic disease state, adjunctive medication, and the coagulation disturbances induced by cardiopulmonary bypass. The following review introduces the monitors that are available for monitoring perioperative coagulation, with an emphasis on cardiovascular surgery. Heparin monitors, platelet function monitors for use in transfusion algorithms, and monitoring anti-platelet drugs will be discussed.
Related Concept Videos
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
